Results 241 to 250 of about 265,748 (319)

Real-world effectiveness of nirsevimab against respiratory syncytial virus in pediatric practice: the Piemonitorab study. [PDF]

open access: yesItal J Pediatr
Funiciello E   +8 more
europepmc   +1 more source

Economic Burden of Respiratory Syncytial Virus Infection in Colombia: A Nationwide Cost-of-Illness Study. [PDF]

open access: yesJ Health Econ Outcomes Res
Buitrago G   +7 more
europepmc   +1 more source

Nirsevimab Prophylaxis and Respiratory Syncytial Virus Hospitalizations Among Infants.

open access: yesJAMA Netw Open
Cocchi E   +13 more
europepmc   +1 more source

Clinical and economic evaluation of risk factor guided respiratory syncytial virus prophylaxis in Colombian preterm infants. [PDF]

open access: yesCost Eff Resour Alloc
Rodriguez-Martinez CE   +12 more
europepmc   +1 more source

Respiratory Syncytial Virus in Hematopoietic Cell Transplant Recipients: Clinical and Humoral Risk Factors for Infection. [PDF]

open access: yesOpen Forum Infect Dis
Pernikoff S   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy